Beyond Embryo Politics
By Emily Galpern,
The Women's Health Activist: Newsletter of the National Women's Health Network
| 04. 30. 2006
Women's Health and Dignity in Stem Cell Research
May / June 2006
"Which comes first-the egg or the cure?" asks an advertisement enticing young women to provide their eggs for stem cell research. The ad lists several diseases and asserts that "It could happen to you or your loved one", and encourages the reader to: "Let your eggs be part of the cure." These slogans mark the re-entry of U.S. scientists into what many see as a global stem cell race. The downfall of disgraced South Korean scientist Hwang Woo-suk, who fabricated data to support his claim that he harvested stem cells from a cloned human embryo, has prompted scientists to scramble to truly be "the first."
The hype around stem cell research and the resulting media attention have raised public hopes that research will soon lead to cures for chronic diseases such as diabetes and Parkinson's. These hopes overshadow serious risks associated with one approach to stem cell research that has been receiving increased attention from scientists. This technique, somatic cell nuclear transfer (SCNT) or "research cloning", raises serious concerns because it requires a huge number of...
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
By Judd Boaz and Elise Kinsella, ABC News | 03.17.2026
By Ryan Cross, Endpoints News | 03.24.2026
Cathy Tie has an audacity more typical of a tech startup founder than a biotech executive. She dropped out of college to start a genetic screening company and later founded a telemedicine startup. The 29-year-old has been on two Forbes...